MORF Morphic Holding Inc.
21.38
+0.28 (+1%)
Previous Close
21.1
Open
20.92
Price To Book
-9.9
Market Cap
652,158,587
Shares
30,503,208
Volume
77,384
Short Ratio
Av. Daily Volume
76,367
NewsSee all news
- Morphic Announces Corporate Highlights and Second Quarter 2019 Financial Results
- Pandion Therapeutics Appoints Rahul Kakkar, MD, as Chief Executive Officer
- Morphic Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
- Morphic Announces Pricing of Upsized Initial Public Offering
Drug Information
Drug catalyst information is displayed when you hover over the stage bar graph.
IND filing due late-2019.
MORF-720
Idiopathic pulmonary fibrosis
IND filing due mid-2020.
MRb7 #1
inflammatory bowel disease
Latest News
- Morphic Announces Corporate Highlights and Second Quarter 2019 Financial Results
- Pandion Therapeutics Appoints Rahul Kakkar, MD, as Chief Executive Officer
- Morphic Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
- Morphic Announces Pricing of Upsized Initial Public Offering